Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel
LON:4BB

4basebio Final Earnings Report

4basebio logo
GBX 550 +20.00 (+3.77%)
As of 11:50 AM Eastern
ProfileEarnings HistoryForecast

4basebio EPS Results

Actual EPS
-GBX 1.09
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

4basebio Revenue Results

Actual Revenue
$1.69 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

4basebio Announcement Details

Quarter
Final
Date
5/20/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

4basebio Earnings Headlines

4basebio CEO Increases Stake with Market Purchase of Ordinary Shares
May 22, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/4basebio-ceo-increases-stake-with-market-purchase-of-ordinary-shares?utm_source=marketbeat.com&utm_medium=referral
4basebio PLC
May 22, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/4bb/financials?countrycode=uk
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,000%. Now he says SpaceX is shaping up to be the biggest IPO of the decade - and three key milestones just confirmed it. In the past 21 days: SpaceX crossed 10,000 active satellites, Elon filed confidential IPO paperwork with the SEC, and another rocket launched 25 more satellites. Two-thirds of every satellite in orbit now belongs to one company. The public filing could drop any day.tc pixel
June 1 at 1:00 AM  |  Brownstone Research (Ad)
4basebio Plc - 4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/4basebio-plc-4basebio-signs-clinical-060000075.html
Final Results and Notice of AGM
May 20, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/final-results-and-notice-of-agm-1036178747
4basebio Signs Clinical Supply Agreement to Support Phase II Clinical Trial
May 20, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/4basebio-signs-clinical-supply-agreement-110000880.html
See More 4basebio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like 4basebio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on 4basebio and other key companies, straight to your email.

About 4basebio

4basebio (LON:4BB) is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

View 4basebio Profile
Earnings Tools